MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL

BACKGROUND: MicroRNAs are known to inhibit gene expression by binding to the 3′UTR of the target transcript. Downregulation of miR-223 has been recently reported to have prognostic significance in CLL. However, there is no evidence of the pathogenetic mechanism of this miRNA in CLL patients. METHODS...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Rodríguez-Vicente, Ana E, Quwaider, Dalia, Benito, Rocío, Misiewicz-Krzeminska, Irena, Hernández-Sánchez, María, de Coca, Alfonso García, Fisac, Rosa, Alonso, José-María, Zato, Carolina, de Paz, Juan Francisco, García, Juan Luis, Sarasquete, Ma Eugenia, Hernández, José Ángel, Corchado, Juan M, González, Marcos, Gutiérrez, Norma C, Hernández-Rivas, Jesús-María
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404064/
https://ncbi.nlm.nih.gov/pubmed/25880332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1212-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia